Bioinnovation —
Vision and objectives
KAUST Smart-Health Initiative (KSHI) aims to operate as an incubator to accelerate research innovation in life science, biology, AI, precision medicine and drive the development of new solutions by early-stage life science start-ups and promote entrepreneurship initiatives from junior and senior scientist from KAUST and beyond.
Latest achievements
20 December, 2020
KAUST announced a collaboration with Janssen Pharmaceutical Companies of Johnson & Johnson to explore opportunities for research and innovation in the area of neglected tropical diseases, with a focus on dengue fever.
08 November, 2020
The COVID-19 pandemic has activated vital innovation and R&D initiatives to tackle the crippling effects, health ramifications, and overall impact of the coronavirus on global societies and economies.
25 August, 2020
KAUST PIs to contribute through their research capabilities to alleviate the COVID-19 pandemic, efforts coordinated by Donal Bradley, KAUST vice president for research, and Pierre Magistretti, KAUST dean of the Biological and Environmental Science and Engineering division, mobilized a group of faculty to form the Rapid Research Response Team (R3T).